Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SHBG | P04278 | 4/20 | 0.52 |
| ▸ | AR | P10275 | 8/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | PGR | P06401 | 6/20 | 0.48 |
| ▸ | NR3C2 | P08235 | 2/20 | 0.48 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Mibolerone SCHEMBL4362587 | 0.81 | AR (0.67) | SHBGARALDH1A1PGRNR3C2 | |
| Mibolerone SCHEMBL10603681 | 0.81 | AR (0.67) | SHBGARALDH1A1PGRNR3C2 | |
| Mibolerone SCHEMBL565277 | 0.81 | AR (0.67) | SHBGARALDH1A1PGRNR3C2 | |
| Mibolerone SCHEMBL14275154 | 0.81 | AR (0.67) | SHBGARALDH1A1PGRNR3C2 | |
| SCHEMBL5520129 | 0.79 | AR (0.68) | SHBGARALDH1A1PGRNR3C2 | |
| SCHEMBL4586771 | 0.79 | AR (0.50) | SHBGARPGRNR3C2 | |
| SCHEMBL14342103 | 0.79 | AR (0.68) | SHBGARALDH1A1PGRNR3C2 | |
| SCHEMBL14342102 | 0.79 | AR (0.50) | SHBGARPGRNR3C2 | |
| Mibolerone SCHEMBL15201510 | 0.76 | AR (0.60) | SHBGARALDH1A1PGRNR3C2 | |
| SCHEMBL6017712 | 0.76 | SHBG (0.71) | SHBGARALDH1A1PGRNR3C2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7018648-B2 | Transdermal device for administering testosterone or one of the derivatives thereof | PIERRE FABRE MEDICAMENT (FR) | 2006-03-28 | — | — | US | disclosed |
| US-20050256051-A1 | Nuclear receptor-mediated introduction of a PNA into cell nuclei | THE POPULATION COUNCIL, INC. (US) | 2005-11-17 | — | — | US | disclosed |
| EP-1178806-B1 | TRANSDERMAL DEVICE FOR THE APPLICATION OF TESTOSTERONE OR ONE OF THE DERIVATIVES THEREOF | PF MEDICAMENT (FR) | 2004-09-01 | — | — | EP | disclosed |
| US-6767902-B2 | Androgen as a male contraceptive and non-contraceptive androgen replacement | THE POPULATION COUNCIL, INC. | 2004-07-27 | — | — | US | disclosed |
| US-20040132698-A1 | Androgen as a male contraceptive and non-contraceptive androgen replacement | MOO-YOUNG ALFRED J (US) | 2004-07-08 | — | — | US | disclosed |
| US-20040126418-A1 | Transdermal administration of MENT | THE POPULATION COUNCIL, INC. | 2004-07-01 | — | — | US | disclosed |
| US-20030096739-A1 | Nuclear receptor-mediated introduction of a PNA into cell nuclei | POPULATION COUNCIL, INC., THE | 2003-05-22 | — | — | US | disclosed |
| US-20020193359-A1 | Administering to a non-sterile male subject a predetermined amount of an androgen which is sufficient to render male subject reversibly sterile for a predetermined period of time | POPULATION COUNCIL, INC., THE | 2002-12-19 | — | — | US | disclosed |
| EP-1178806-A1 | TRANSDERMAL DEVICE FOR THE APPLICATION OF TESTOSTERONE OR ONE OF THE DERIVATIVES THEREOF | PIERRE FABRE MEDICAMENT (FR) | 2002-02-13 | — | — | EP | disclosed |
| US-20020012694-A1 | TRANSDERMAL ADMINISTRATION OF MENT | POPULATION COUNCIL, INC., THE, A CORP. OF NY | 2002-01-31 | — | — | US | disclosed |
| WO-2000071133-A1 | TRANSDERMAL DEVICE FOR THE APPLICATION OF TESTOSTERONE OR ONE OF THE DERIVATIVES THEREOF | PIERRE FABRE MEDICAMENT (FR) | 2000-11-30 | — | — | WO | disclosed |
| US-5342834-A | Administering testosterone derivatives | THE POPULATION COUNCIL, INC. (US) | 1994-08-30 | — | — | US | disclosed |